Buddy-In

Spec sheet

Purpose

Buddy-In is a digital medical device for social-skills training for children and adolescents aged 10–18 with ASD or Social (Pragmatic) Communication Disorder.Read 14 Nov 2026 · neudive.com

Support

Neudive lists weekday support hours of 09:00–18:00 and provides a phone number and email address.Read 14 Nov 2026 · neudive.com

Headquarters

Daegu, South KoreaRead 19 Oct 2026 · neudive.com

Founded

2022Read 19 Oct 2026 · neudive.com

Maker

Neudive says it was founded in 2022 and lists its headquarters in Daegu, South Korea.Read 14 Nov 2026 · neudive.com

Clinical evidence

Neudive says exploratory and confirmatory clinical trials were completed and found safety and improvement in Adaptive Behavior Composite score versus control.Read 14 Nov 2026 · neudive.com

Clinician monitoring

The system records usage, performance, and training progress for clinicians to monitor in real time.Read 14 Nov 2026 · neudive.com

Medical-device certification

Buddy-In received MFDS manufacturing certification as a Class II digital medical device on May 7, 2026.Read 14 Nov 2026 · neudive.com

Parent reports

Parents receive reports about what their child is learning and changes in social skills over time.Read 14 Nov 2026 · neudive.com

Personalized scenarios

Mobile scenario-based games and an algorithm-driven structure tailor training to each user's level.Read 14 Nov 2026 · neudive.com

Prescription

Buddy-In is prescribed by a medical professional following diagnosis and assessment of suitability.Read 14 Nov 2026 · neudive.com

Therapy approach

Buddy-In is based on Cognitive Behavioral Therapy and Social Skills Training.Read 14 Nov 2026 · neudive.com

Training schedule

The program is designed for 30 sessions over six weeks, five times a week, for about 10 minutes per session.Read 14 Nov 2026 · neudive.com

Use alongside treatment

Buddy-In is intended to complement, not replace, existing treatment or in-person support.Read 14 Nov 2026 · neudive.com

Use caution

The maker recommends guardian monitoring and stopping use if discomfort or unusual behavior occurs.Read 14 Nov 2026 · neudive.com

Where Specifiction places it

• Autism Learning Apps#9 of 307.0